JB Chemicals to Seek Shareholder Vote on Merger with Torrent Pharma

JB Chemicals & Pharmaceuticals Ltd. is calling a video‑conference meeting on 28 April 2026 to ask shareholders to approve a share‑based merger with Torrent Pharmaceuticals Ltd..

• Voting timeline: Remote e‑voting runs from 24 April 2026 09:00 IST to 27 April 2026 17:00 IST; voting rights cut‑off is 21 April 2026.
• Deal structure: Under a Scheme of Amalgamation, JB Pharma (transferor) will merge into Torrent Pharma (transferee). JB shareholders will receive Torrent shares at a ratio set by a joint EY‑BDO valuation (see Annexure‑6). No cash outflow for shareholders.
• Strategic upside: The combined entity aims for a larger product pipeline, broader distribution, and cost‑saving synergies that could lift earnings per share and profit margins.
• Regulatory & approval risk: The scheme still needs clearances from SEBI, BSE, NSE and other bodies, plus a majority shareholder vote; a negative vote or regulatory delay would stall the merger.
• What investors should do: Review the scheme documents (Annexures 1‑8) on the company website, cast their vote during the e‑voting window, and monitor the vote outcome and subsequent Tribunal approval.